Literature DB >> 7883280

Long term effects of atenolol in patients of mitral stenosis & normal sinus rhythm.

H M Mardikar1, V S Sahasrabhojaney, P D Jalgaonkar, U M Mahorkar, M H Mardikar, B G Waghmare.   

Abstract

We studied the effect of atenolol 100 mg/day in 50 symptomatic patients of mitral stenosis and normal sinus rhythm, in a placebo controlled study. Atenolol caused significant bradycardia as compared to placebo (vitamin C; P < 0.001) without any adverse effects. It also increased exercise capacity significantly as compared to placebo (P < 0.001). All the patients were followed up to the period of 9 months and no adverse effects were seen. We conclude that beta adrenergic blocking drugs like atenolol can be used as the only treatment for patients with mitral stenosis without congestive heart failure and in sinus rhythm, for long-term symptomatic relief.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883280

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  1 in total

1.  A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm.

Authors:  Gopalan Nair Rajesh; Kalathingathodika Sajeer; Chakanalil Govindan Sajeev; Cicy Bastian; Desabandhu Vinayakumar; Kader Muneer; Vellani Haridasan; Dolly Mathew; Biju George; Mangalath Narayanan Krishnan
Journal:  Indian Heart J       Date:  2016-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.